RBF Capital, LLC - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 86 filers reported holding HOMOLOGY MEDICINES INC in Q2 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
RBF Capital, LLC ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2023$68,679
+32.2%
58,7000.0%0.01%
+66.7%
Q2 2023$51,950
-14.1%
58,7000.0%0.00%
-25.0%
Q1 2023$60,461
-35.7%
58,700
-21.6%
0.00%
-42.9%
Q4 2022$94,000
-3.1%
74,912
+24.9%
0.01%
-12.5%
Q3 2022$97,000
-17.8%
60,0000.0%0.01%0.0%
Q2 2022$118,00060,0000.01%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q2 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$51,211,00017.25%
Vida Ventures Advisors, LLC 770,845$8,703,0001.79%
AAF Wealth Management, LLC 59,790$675,0000.61%
Vivo Capital, LLC 853,143$9,632,0000.43%
Bellevue Group AG 1,737,122$19,612,0000.22%
PREMIER ASSET MANAGEMENT LLC 77,108$871,0000.18%
Temasek Holdings (Private) Ltd 3,220,293$36,357,0000.16%
American Investment Services, Inc. 36,955$417,0000.13%
Virtus ETF Advisers LLC 24,646$278,0000.12%
FIRST MIDWEST BANK TRUST DIVISION 65,983$745,0000.11%
View complete list of HOMOLOGY MEDICINES INC shareholders